Alerts will be sent to your verified email
Verify Email
SMSPHARMA
|
SMS Pharmaceuticals
|
Aarti Drugs
|
Supriya Lifescience
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceuticals
|
|||
|
R&D as a % of Total Sales
|
2.4 % | 1.93 % | n/a |
|
Financials
|
|||
|
5 yr Average ROE
|
9.71 % | 18.02 % | 23.4 % |
|
5yr average Equity Multiplier
|
1.92 | 1.97 | 1.25 |
|
5yr Average Asset Turnover Ratio
|
0.64 | 1.09 | 0.68 |
|
5yr Avg Net Profit Margin
|
7.52 % | 8.24 % | 25.52 % |
|
Price to Book
|
5.01 | 2.21 | 4.59 |
|
P/E
|
40.75 | 15.99 | 26.78 |
|
5yr Avg Cash Conversion Cycle
|
95.74 Days | 79.88 Days | -10.96 Days |
|
Inventory Days
|
117.18 Days | 69.48 Days | 56.1 Days |
|
Days Receivable
|
94.73 Days | 111.3 Days | 57.43 Days |
|
Days Payable
|
94.13 Days | 97.75 Days | 113.66 Days |
|
5yr Average Interest Coverage Ratio
|
4.95 | 9.61 | 60.74 |
|
5yr Avg ROCE
|
12.07 % | 21.16 % | 30.51 % |
|
5yr Avg Operating Profit Margin
|
17.65 % | 14.01 % | 36.15 % |
|
5 yr average Debt to Equity
|
0.54 | 0.46 | 0.06 |
|
5yr CAGR Net Profit
|
2.03 % | -9.72 % | 8.75 % |
|
5yr Average Return on Assets
|
4.9 % | 9.12 % | 17.81 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
68.07 % | 55.03 % | 68.3 % |
|
Share Pledged by Promoters
|
17.99 % | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
3.9 % | -4.63 % | 0.06 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
3.21 % | 6.21 % | -1.71 % |
|
SMS Pharmaceuticals
|
Aarti Drugs
|
Supriya Lifescience
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Segment Break-Up
|
Segment Break-Up
|
-
|
-
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
|
Therapeutic Area Break-Up
|
Therapeutic Area Break-Up
|
Therapeutic Area Break-Up
|
Therapeutic Area Break-Up
|
|
Asset Break-Up
|
Asset Break-Up
|
-
|
-
|